Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 28;38(11):134.
doi: 10.1007/s12032-021-01587-7.

Cancer induced bone pain: current management and future perspectives

Ruchi Kapoor  1 , Ashok Kumar Saxena  1 , Prerna Vasudev  1 , Deepak Sundriyal  2 , Arvind Kumar  3
Affiliations
Review

Cancer induced bone pain: current management and future perspectives

Ruchi Kapoor et al. Med Oncol. .

Abstract

Recent improvements in the therapeutic armamentarium of oncology by the addition of targeted and immunotherapeutic agents have led to an increase in the life expectancy of advanced-stage cancer patients. This has led to an increased number of patients presenting with bone metastasis and experiencing episodes of cancer-induced bone pain (CIBP). CIBP is a crippling, chronic, morbid state interfering significantly with the functional capacity and the quality of life (QoL). CIBP is characterized by a complex multifactorial pathophysiological mechanism involving tumor cells, bone cells, inflammatory microenvironment, and the neuronal tissue. It may not be possible to mitigate pain completely; therefore, the aim should be to reach the lowest possible level of pain that allows for an acceptable QoL to the patient. Multimodality approach of surgical, radiation, medical and behavioral techniques is thus recommended to manage CIBP. This review discusses the pathogenesis and pathophysiological mechanism accompanying bone metastasis and CIBP, currently approved therapies for the management of CIBP, and the future perspective.

Keywords: Bone metastasis; Cancer induced bone pain; Osteoclast inhibitors; Quality of life.

PubMed Disclaimer

References

    1. Shibata H, Kato S, Sekine I, et al. Diagnosis and treatment of bone metastasis: Comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology. ESMO Open. 2016. https://doi.org/10.1136/esmoopen-2016-000037 . - DOI - PubMed - PMC
    1. Coleman RE. Skeletal complications of malignancy. Cancer. 1997;80:1588–94. - DOI
    1. Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001;27:165–76. - DOI
    1. Huang JF, Shen J, Li X, et al. Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study. Ann Transl Med. 2020;8(7):482. - DOI
    1. Bubendorf L, Schöpfer A, Wagner U, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000;31(5):578–83. - DOI

Substances

LinkOut - more resources